BRCA2 and breast cancer: First, the familial breast-ovarian cancer either due to heterozygous germline mutations in BRCA1 (OMIM #604370) or BRCA2 (OMIM #612555), because the index patient and her sister had early-age-onset (≤50 years) breast cancer and the index patient bilateral disease [4].